About VGXI
VGXI is a company based in The Woodlands (United States) founded in 1997. VGXI operates in a competitive market with competitors including Metabolon, Maze Therapeutics, Seer, Alector and Scailyte, among others.
- Headquarter The Woodlands, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of VGXI
Unlock access to complete
Funding Insights of VGXI
Investors in VGXI
VGXI has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include CEPI.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare investments are targeted by this private equity firm.
|
Locked | Locked | Locked |
Investor details for VGXI
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by VGXI
Investment portfolio details for VGXI
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - VGXI
Detailed financials for VGXI
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vgxi Comparisons
Peer comparison for VGXI
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of VGXI
VGXI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Metabolon, Maze Therapeutics, Seer, Alector and Scailyte, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Solutions for biomarker discovery and diagnostic testing are provided.
|
|
| Locked | Locked | Locked |
Genetic biomarkers are developed for neurological, metabolic, and renal diseases.
|
|
| Locked | Locked | Locked |
Proteomics platform developed for early cancer and neurological disease detection.
|
|
| Locked | Locked | Locked |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed.
|
|
| Locked | Locked | Locked |
Single-cell data is analyzed via AI for biomarker discovery.
|
|
| Locked | Locked | Locked |
NeoPhore is focused on cancer neoantigen evolution therapies.
|
Detailed competitors of VGXI
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vgxi
Complete news archive for VGXI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VGXI
VGXI was founded in 1997 and raised its 1st funding round 23 years after it was founded.
VGXI is headquartered in The Woodlands, United States. It is registered at The Woodlands, Texas, United States.
Young K Park is the current CEO of VGXI.
VGXI was established in 1997 as a contract manufacturing organization in the biotechnology sector, based in The Woodlands, United States. Services encompass cGMP plasmid DNA production for clinical and commercial applications, highly documented plasmids for viral and toxicological studies, and high-purity preparations for preclinical research. As a subsidiary of GeneOne Life Science, operations support DNA vaccine and gene therapy development.
VGXI's top competitors include Alector, Maze Therapeutics and Metabolon.
VGXI has 1 investor. Key investors include CEPI.